Rifaximin is an efficacious treatment for the parkinsonian phenotype of hepatic encephalopathy
Authors:
- Christopher CloughCCChristopher Clough
- Debbie L. ShawcrossDSDebbie L. Shawcross
Open Access
- 7 March 2013
- journal article
- other
- Published by Wolters Kluwer Health in Hepatology
- Vol. 58 (4) , 1516-1517
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Rifaximin Reduces Endotoxemia and Improves Liver Function and Disease Severity in Patients With Decompensated CirrhosisHepatology, 2011
- Rifaximin in hepatic encephalopathy: More than just a non-absorbable antibiotic?Journal of Hepatology, 2010
- Rifaximin Treatment in Hepatic EncephalopathyNew England Journal of Medicine, 2010
- MR Imaging Findings in Hepatic EncephalopathyAmerican Journal of Neuroradiology, 2008
- Chronic Parkinsonism Associated With CirrhosisArchives of Neurology, 2003